Longitudinal analysis of cell-free mutated KRAS and CA 19–9 predicts survival following curative resection of pancreatic cancer

Ítems similars

• Metabolic Profiling of Early and Late Recurrent Pancreatic Ductal Adenocarcinoma Using Patient-Derived Organoid Cultures
  per: Braun, Lukas M., et al.
  Publicat: (2020)
• Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management
  per: Wehrle, Julius, et al.
  Publicat: (2020)
• Chronic Myelogenous Leukemia: Treatment and Monitoring
  per: von Bubnoff, Nikolas, et al.
  Publicat: (2010)
• Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma
  per: Rittmann, Marie-Claire, et al.
  Publicat: (2021)
• Asymmetric kinase dimer formation is crucial for the activation of oncogenic EGFRvIII but not for ERBB3 phosphorylation
  per: Kancha, Rama Krishna, et al.
  Publicat: (2013)